Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas J Simmonds

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
The Lancet. Respiratory Medicine|August 2, 2025
Maximising opportunity for therapeutic success: sequential participation in cystic fibrosis nucleic acid-based therapy trialsNicole Mayer-Hamblett, Natanya R Kerper, John P Clancy, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 9, 2020
Safety and efficacy of the cystic fibrosis transmembrane conductance regulator potentiator icenticaftor (QBW251)Shamsah Kazani, David J Rowlands, Ivan Bottoli, et al.
Mycoses|April 28, 2018
Airway persistence by the emerging multi-azole-resistant Rasamsonia argillacea complex in cystic fibrosisAlireza Abdolrasouli, Amelia C Bercusson, Johanna L Rhodes, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|May 14, 2025
Managing an ageing cystic fibrosis population: challenges and prioritiesFreddy J Frost, Daniel G Peckham, Imogen C Felton, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 29, 2023
Standards for the care of people with cystic fibrosis (CF): A timely and accurate diagnosisCarlo Castellani, Nicholas J Simmonds, Jürg Barben, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 2, 2026
Effects of Elexacaftor/Tezacaftor/Ivacaftor on cough frequency, physical activity patterns, and sleep quality in adolescents and adults with cystic fibrosisEva Van Braeckel, Andrew T Braun, Nicholas J Simmonds, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 20, 2026
Determinants of early Elexacaftor-Tezacaftor-Ivacaftor use in adults with cystic fibrosis and preserved lung function: insights from a European multicenter surveyAndrea Gramegna, Carlo Magnoni, Chiara Premuda, et al.
The Lancet. Respiratory Medicine|July 8, 2015
Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trialEric W F W Alton, David K Armstrong, Deborah Ashby, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
The Lancet. Respiratory Medicine|August 2, 2025
Maximising opportunity for therapeutic success: sequential participation in cystic fibrosis nucleic acid-based therapy trialsNicole Mayer-Hamblett, Natanya R Kerper, John P Clancy, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 9, 2020
Safety and efficacy of the cystic fibrosis transmembrane conductance regulator potentiator icenticaftor (QBW251)Shamsah Kazani, David J Rowlands, Ivan Bottoli, et al.
Mycoses|April 28, 2018
Airway persistence by the emerging multi-azole-resistant Rasamsonia argillacea complex in cystic fibrosisAlireza Abdolrasouli, Amelia C Bercusson, Johanna L Rhodes, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|May 14, 2025
Managing an ageing cystic fibrosis population: challenges and prioritiesFreddy J Frost, Daniel G Peckham, Imogen C Felton, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 29, 2023
Standards for the care of people with cystic fibrosis (CF): A timely and accurate diagnosisCarlo Castellani, Nicholas J Simmonds, Jürg Barben, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 2, 2026
Effects of Elexacaftor/Tezacaftor/Ivacaftor on cough frequency, physical activity patterns, and sleep quality in adolescents and adults with cystic fibrosisEva Van Braeckel, Andrew T Braun, Nicholas J Simmonds, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 20, 2026
Determinants of early Elexacaftor-Tezacaftor-Ivacaftor use in adults with cystic fibrosis and preserved lung function: insights from a European multicenter surveyAndrea Gramegna, Carlo Magnoni, Chiara Premuda, et al.
The Lancet. Respiratory Medicine|July 8, 2015
Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trialEric W F W Alton, David K Armstrong, Deborah Ashby, et al.
Pageof 7